x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Market Lens

Welcome to Market Lens, your fresh take on the financial markets.Each week, we break down the latest headlines, offer clear analysis of stocks, ETFs, and major trends, and share practical trading strategies and investing tips you can use right away. You’ll get honest conversations about risks and opportunities, plus short educational segments to help you build your financial skills and make smarter decisions.Tune in to cut through the noise, stay ahead of the markets, and get the edge you need—one

business investing

All Episodes

1:38

Eli Lilly's Collaboration with SanegeneBio on RNAi...

Market Lens ·

2025/11/09

Send us a text This episode focus on the RNA interference (RNAi) therapeutics market, highlighting both the broader industry landscape and a major strategic collaboration. One source provides an overview of eight leading RNAi therapeutics companies, such as Alnylam and Roche, detailing their proprietary delivery platforms and competitive positions in treating various diseases. The remaining sources all report on a significant agreement between Eli Lilly and SanegeneBio, where Lilly is investi...

en-us

1:29

Why Wall St Backs Micron's Bullish Investment Thesis?

Market Lens ·

2025/11/08

Send us a text This podcast provides an extensive overview of the bullish investment thesis for Micron Technology, arguing that the stock is currently undervalued despite a significant price surge. The core argument centers on the AI-driven memory boom, noting that Micron has secured substantial market share in High-Bandwidth Memory (HBM), leading to a massive increase in related revenues. Furthermore, the company exhibits strong financial fundamentals, with record revenues, soaring adjusted ...

en-us

2:00

Supreme Court Scrutiny of Trump Tariffs Under IEEPA

Market Lens ·

2025/11/08

Send us a text This podcast provides an overview of the legal and economic implications surrounding the Supreme Court's consideration of tariffs imposed by the Trump administration under the International Economic Emergency Powers Act (IEEPA). The articles from SCOTUSblog, Brookings, and the Atlantic Council address the skepticism expressed by the Supreme Court regarding the President's authority to unilaterally impose such widespread tariffs, arguing that the IEEPA statute likely does not gr...

en-us

1:38

Disney's Big Pivot: How Streaming Profits and Theme...

Market Lens ·

2025/11/08

Send us a text This episode offers a multifaceted look at The Walt Disney Company's financial performance and strategic direction across its various segments. The Nasdaq excerpt provides an in-depth investment analysis recommending a "Hold" position on Disney stock, noting its discounted valuation despite significant growth in its Experiences segment and achieving a streaming profitability milestone. Separately, a Marketing Brew article discusses Disney's ongoing commitment to its linear tele...

en-us

1:36

Meta's $600 Billion AI Data Center Investment in the US

Market Lens ·

2025/11/08

Send us a text This episode provides a comprehensive look at Meta's massive investment in artificial intelligence (AI) infrastructure across the United States, committing over $600 billion by 2028 primarily for AI-optimized data centers. The Meta newsroom source highlights the company's intention to drive economic growth, support over 35,000 jobs, and strengthen local communities through investments in municipal infrastructure and grants, all while striving for water positive operations by 20...

en-us

1:56

Brazil's Paradox: Oil, Investment, and Energy Transition

Market Lens ·

2025/11/07

Send us a text This episode focus on Brazil's energy transition and the paradoxical role of oil revenue in funding green initiatives. Several sources detail Brazil's efforts, including the Eco Invest Brasil program and multi-billion-dollar commitments from multilateral agencies like the IDB to boost foreign investment and reduce currency risk in decarbonization projects. Conversely, Brazil's state-controlled oil company, Petrobras, is expanding oil and gas exploration, particularly in the Equ...

en-us

1:53

ESPN-DraftKings Partnership After Penn Exit

Market Lens ·

2025/11/07

Send us a text This episode details the early termination of the online sports betting partnership between ESPN and PENN Entertainment, which operated the ESPN Bet platform, due to its failure to meet market share targets. This abrupt ending of the expensive, ten-year deal, signed in 2023, results in PENN Entertainment rebranding its sportsbook app as theScore Bet by December 1, 2025, while retaining nearly three million user accounts. Simultaneously, ESPN announced a new multi-year agreement...

en-us

1:53

Peloton's Turnaround: Subscription Value

Market Lens ·

2025/11/07

Send us a text This podcast centers on the financial outlook and turnaround strategy of Peloton, focusing heavily on the value of its subscription business despite challenges in hardware sales and significant debt. One Reddit post argues that Peloton is undervalued when its high-margin, growing subscription revenue is considered separately from its declining product revenue, even comparing it favorably to Netflix’s gross margins. Complementary news articles report that Peloton's shares jumped...

en-us

2:01

Comcast's Proposed ITV Acquisition

Market Lens ·

2025/11/07

Send us a text This podcast focus primarily on the proposed acquisition of ITV's media and entertainment division by Comcast, the American telecommunications giant that owns Sky. This potential deal, valued around £1.6 billion to $2.1 billion, involves the sale of ITV's linear channels and the streaming platform ITVX, but excludes the lucrative ITV Studios production arm. The sources analyze the strategic rationale behind the move, noting that combining Sky and ITV's advertising operations co...

en-us

1:34

Tesla's AI Chip Strategy: Intel Partnership

Market Lens ·

2025/11/07

Send us a text This episode provides an overview of a potential, but yet unsigned, partnership between Tesla and Intel regarding the manufacturing of Tesla’s next-generation AI chips. Driven by its growing demand for custom silicon to power its autonomous driving (FSD) and robotics ambitions, Tesla CEO Elon Musk proposed the idea of building a massive internal "terafab" but also mentioned discussions with Intel Foundry as a strategic alternative to secure high-volume production. This move sig...

en-us

1:58

Media Megadeal Showdown: Warner Bros. + Discovery

Market Lens ·

2025/11/06

Send us a text This podcast provides an overview of the intense acquisition pursuit of Warner Bros. Discovery (WBD) by Paramount Skydance (PSKY), which includes a rejected $23.50-per-share offer and the threat of a hostile takeover if WBD's board continues to refuse negotiation. WBD is actively exploring strategic alternatives, including a company split or asset sales, with a decision expected by Christmas. Analysts largely view a merger as strategically and economically beneficial due to sub...

en-us

1:36

GLP-1 Drug Stocks Risk: Medicare Deals vs. 2026...

Market Lens ·

2025/11/06

Send us a text This episode offers conflicting reports regarding the Trump administration's policy on Medicare coverage for GLP-1 drugs used for weight loss. The first source, an article from Investopedia dated November 2025, claims that a new plan would cover popular drugs like Ozempic and Wegovy for Medicare patients for as little as $50 a month, due to negotiated lower prices with pharmaceutical companies. Conversely, the second source, a Pharmaceutical Technology article from April 2025, ...

en-us

1:31

Denny's Taken Private in $620 Million Leveraged Buyout

Market Lens ·

2025/11/06

Send us a text This podcast primarily discusses the impending $620 million acquisition of Denny's Corporation, which will result in the publicly traded company becoming a private entity. The purchase is being executed by a consortium composed of TriArtisan Capital Advisors, Treville Capital Group, and Yadav Enterprises, which is notably one of Denny's largest franchisees. Shareholders will receive $6.25 per share in cash, representing a significant premium over the recent closing price, a mov...

en-us

1:56

Ironwood: Google’s Cost-Crushing Answer to Nvidia in...

Market Lens ·

2025/11/06

Send us a text This episode offers an overview of Google's Ironwood Tensor Processing Unit (TPU), focusing on its implications for the AI industry and the company’s competition with Nvidia. One source, a Reddit discussion, showcases varied opinions, with some asserting that Ironwood's specialization in AI inference will grant Google a cost and speed advantage for its internal services like Gemini, while others debate the accuracy of initial comparison charts and note that Google currently off...

en-us

1:39

Snap's $400 Million Perplexity AI Integration

Market Lens ·

2025/11/06

Send us a text This episode provides a comprehensive overview of a significant $400 million partnership between Snap Inc., the company behind Snapchat, and Perplexity AI, an AI-powered answer engine. This deal involves Perplexity paying Snap a mix of cash and equity to embed its conversational AI search technology directly into the Snapchat app's My AI feature, with the integration expected to roll out in early 2026 and revenue recognition for Snap beginning the same year. The strategic goal ...

en-us

2:07

Supreme Court Challenge to Presidential Tariff Power

Market Lens ·

2025/11/05

Send us a text This podcast provides a comprehensive overview of the Supreme Court oral arguments concerning the legality of President Trump’s tariffs, which were imposed under the International Emergency Economic Powers Act (IEEPA). The articles and press release from California Governor Newsom emphasize the legal challenge to the tariffs, arguing that IEEPA does not grant the president unlimited authority to impose taxes (tariffs), a power explicitly reserved for Congress, thereby raising a...

en-us

2:17

Inside the Lab Where Beam Therapeutics is Rewriting...

Market Lens ·

2025/11/05

Send us a text This episode provides an extensive overview of Beam Therapeutics, a biotechnology company focused on developing genetic medicines using base editing technology. Base editing is highlighted as a precise gene-editing approach that chemically modifies a single DNA base without causing the double-stranded DNA breaks associated with traditional CRISPR/Cas9 methods, which is believed to offer superior safety. Several documents describe Beam's pipeline, including lead programs like BE...

en-us

1:42

Inflation Forces Young Diners to Cut Restaurant Spending

Market Lens ·

2025/11/05

Send us a text This episode reports on the fast-casual dining industry's struggle due to younger consumers drastically cutting back on spending, particularly Gen Z and Millennials. Major chains like Chipotle and Cava are experiencing reduced customer traffic and missed sales targets, as economic pressures like inflation, student debt, and a difficult job market force this demographic to prioritize cooking at home. Several articles feature quotes from restaurant executives, such as Chipotle's ...

en-us

1:46

Palantir Paradox: AI Drives Growth and Stock Plunge

Market Lens ·

2025/11/05

Send us a text This episode provides an overview of the market reaction to Palantir Technologies' stellar third-quarter 2025 earnings report, which included record revenues, strong growth in key areas like U.S. commercial revenue, and significantly raised full-year guidance. Despite the overwhelmingly positive financial results, the stock plunged initially because many Wall Street analysts believe the valuation is extremely high following a significant rally throughout the year, citing concer...

en-us

1:36

Exact Sciences Future: Diagnostics, Earnings, and...

Market Lens ·

2025/11/04

Send us a text This episode offers an analysis of Exact Sciences Corporation (NASDAQ: EXAS), highlighting its strong performance in the cancer diagnostics sector. The company, known for products like Cologuard and Oncotype DX, recently reported robust third-quarter results, achieving earnings of 24 cents per share and quarterly sales of $850.7 million, both exceeding analyst expectations. Due to this positive financial momentum, the investment firm Robert W. Baird set an optimistic price targ...

en-us

69 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...